Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC.
The doctrine of equivalents cannot be used to capture unclaimed subject matter disclosed in the specification.
The doctrine of equivalents cannot be used to capture unclaimed subject matter disclosed in the specification.